categories
HOT TOPICS
- The Accelerator Conundrum
- The Startup Velocity Question
- Platform as a Service
- Man and Superman
- Web 3.0 = (4C + P + VS)
- The Future: End of Capitalism
- Capitalism 2.0
medidata
Taking a Capital Efficient Company Public and Beyond: Medidata CEO Tarek Sherif (Part 7)
Sramana Mitra: I remember we talked about it a little bit the last time we spoke. So Veeva has its eyes obviously on the clinical data management space. They have one big customer this year. I think that’s their first big pharmaceutical customer. Can you analyze that deal for us? Tarek Sherif: I can’t analyze
Taking a Capital Efficient Company Public and Beyond: Medidata CEO Tarek Sherif (Part 6)
Sramana Mitra: In 2009 when you went public, what was the market share situation vis a vis you versus FaceForward? Tarek Sherif: They had a larger market share when we went public. They were larger, certainly, in terms of revenue and market share, but we were growing much faster. Sramana Mitra: Were they public? Tarek
Taking a Capital Efficient Company Public and Beyond: Medidata CEO Tarek Sherif (Part 5)
Sramana Mitra: What other strategic moves did you make between the $10 million round and the IPO where you grew revenues tremendously? Was there anything you did strategically? Tarek Sherif: Yes, I think there are a couple of things. Let me take you back one step. So, we had two mantras when we were building
Taking a Capital Efficient Company Public and Beyond: Medidata CEO Tarek Sherif (Part 4)
Sramana Mitra: The first customers that you were getting traction with, how much were they paying you? Tarek Sherif: We tried a couple of different charging models. At first, we thought about a per-patient model. Back then, people were charging per data point. We tried a couple of those and they were frustrating for us.
Taking a Capital Efficient Company Public and Beyond: Medidata CEO Tarek Sherif (Part 3)
Sramana Mitra: Let’s go back to when you decided to get together and start this company. What was the idea? What did they want to do? It sounds like they brought the technical and domain knowledge about the CRO industry. What did they have? What was in their mind that they wanted to do? Tarek
Taking a Capital Efficient Company Public and Beyond: Medidata CEO Tarek Sherif (Part 2)
Tarek Sherif: Working for a large corporation was a good experience in the sense that I figured out what I didn’t want to do. I came out of there determined to never be in a role where I didn’t have a large measure of control. As I used to joke about it, I ended up
Taking a Capital Efficient Company Public and Beyond: Medidata CEO Tarek Sherif (Part 1)
If you haven’t already, please study our Bootstrapping Course and Investor Introductions page. We’ve covered Medidata in TLHIT before. This time, we look at the entrepreneurial journey of this wonderful company. Sramana Mitra: Let’s start at the very beginning of the journey. Where are you from? Where were you born, raised, and in what kind of background? Tarek Sherif:
Thought Leaders in Healthcare IT: Tarek Sherif, CEO of Medidata (Part 7)
Sramana Mitra: How is it that you have 18 out of the top 25 pharma? Given what you describe, it seems to me like you should be having 25 out of the 25. Tareq Sherif: I agree with you. But it’s a business. Sramana Mitra: What is the explanation though? Tareq Sherif: The explanation is,
